Amylase- and endopeptidase- and pancreatic lipase-containing product
RxNorm 1007820
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1007820 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Amylase- and endopeptidase- and pancreatic lipase-containing product.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Amylase- and endopeptidase- and pancreatic lipase-containing product
(Atom ID: 11435294)
FN
Full form of descriptor (FN):
Product containing amylase and endopeptidase and pancreatic lipase (medicinal product)
(Atom ID: 11438229)
Patient Education
Lipase
What is it? Lipase is a compound involved in the break down of fats during digestion. It is found in many plants, animals, bacteria, and molds. Some people use lipase as a medicine.
Lipase is most commonly used for indigestion (dyspepsia), heartburn, and other gastrointestinal problems, but there is no good scientific evidence to support these uses.
Do not confuse lipase with pancreatic enzyme products. Pancreatic enzyme products contain multiple ingredients, including lipase. Some of these products are approved by the US FDA for digestion problems due to a disorder of the pancreas (pancreatic insufficiency).
[Learn More]
* Please review the disclaimer below.